These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15660616)

  • 1. Integrated analysis: combining risk and economic assessments while preserving the separation of powers.
    Williams RA; Thompson KM
    Risk Anal; 2004 Dec; 24(6):1613-23. PubMed ID: 15660616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit adequacy among elderly Social Security retired-worker beneficiaries and the SSI federal benefit rate.
    Rupp K; Strand A; Davies P; Sears J
    Soc Secur Bull; 2007; 67(3):29-51. PubMed ID: 18605217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis in hand surgery.
    Myers J; McCabe S; Gohmann S
    J Hand Surg Am; 2006 Apr; 31(4):664-8. PubMed ID: 16632063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using probabilistic terrorism risk modeling for regulatory benefit-cost analysis: application to the Western hemisphere travel initiative in the land environment.
    Willis HH; LaTourrette T
    Risk Anal; 2008 Apr; 28(2):325-39. PubMed ID: 18419652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic and policy instrument analyses in support of the scrap tire recycling program in Taiwan.
    Chang NB
    J Environ Manage; 2008 Feb; 86(3):435-50. PubMed ID: 17276578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach to risk assessment integrating scientific evaluation and economic assessment of costs and benefits.
    Barnard RC
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):121-5. PubMed ID: 8933625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards quantitative uncertainty assessment for cancer risks: central estimates and probability distributions of risk in dose-response modeling.
    Kopylev L; Chen C; White P
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):203-7. PubMed ID: 17905499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncertainty characterization approaches for risk assessment of DBPs in drinking water: a review.
    Chowdhury S; Champagne P; McLellan PJ
    J Environ Manage; 2009 Apr; 90(5):1680-91. PubMed ID: 19167150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of information analysis in environmental health risk management decisions: past, present, and future.
    Yokota F; Thompson KM
    Risk Anal; 2004 Jun; 24(3):635-50. PubMed ID: 15209935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of epidemiologic data in Integrated Risk Information System (IRIS) assessments.
    Persad AS; Cooper GS
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):137-45. PubMed ID: 18329062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty in biokinetic parameters on bioremediation: health risks and economic implications.
    Wethasinghe C; Yuen ST; Kaluarachchi JJ; Hughes R
    Environ Int; 2006 Apr; 32(3):312-23. PubMed ID: 16055190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the ecological risk assessment process.
    Dale VH; Biddinger GR; Newman MC; Oris JT; Suter GW; Thompson T; Armitage TM; Meyer JL; Allen-King RM; Burton GA; Chapman PM; Conquest LL; Fernandez IJ; Landis WG; Master LL; Mitsch WJ; Mueller TC; Rabeni CF; Rodewald AD; Sanders JG; van Heerden IL
    Integr Environ Assess Manag; 2008 Jul; 4(3):306-13. PubMed ID: 18324871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.
    Claxton K; Sculpher M; McCabe C; Briggs A; Akehurst R; Buxton M; Brazier J; O'Hagan T
    Health Econ; 2005 Apr; 14(4):339-47. PubMed ID: 15736142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effective management of low-risk papillary thyroid carcinoma.
    Shrime MG; Goldstein DP; Seaberg RM; Sawka AM; Rotstein L; Freeman JL; Gullane PJ
    Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1245-53. PubMed ID: 18086967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.